Chris Degnan

Insider Reports History

Entity
Individual
Location
C/O Verrica Pharmaceuticals Inc., 10 North High Street, Suite 200, West Chester, PA
Signature
/s/ Jason D. Smith, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Chris Degnan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Galera Therapeutics, Inc. Chief Financial Officer Common Stock 10K $10.7K $1.07 Mar 13, 2023 Direct
UroGen Pharma Ltd. Chief Financial Officer Employee Stock Option (right to buy) 74.1K Oct 8, 2024 Direct
UroGen Pharma Ltd. Chief Financial Officer Restricted Stock Units 13.5K Oct 8, 2024 Direct

Insider Reports Filed by Chris Degnan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
URGN UroGen Pharma Ltd. Oct 8, 2024 2 $0 4 Oct 9, 2024 Chief Financial Officer
URGN UroGen Pharma Ltd. Oct 8, 2024 0 $0 3 Oct 9, 2024 Chief Financial Officer
GRTX Galera Therapeutics, Inc. Mar 13, 2023 1 $19.6K 4 Mar 14, 2023 Chief Financial Officer
GRTX Galera Therapeutics, Inc. Feb 25, 2023 1 $0 4 Feb 28, 2023 Chief Financial Officer
GRTX Galera Therapeutics, Inc. Feb 28, 2022 1 $0 4 Mar 2, 2022 Chief Financial Officer